FDA approves new drug to protect babies from RSV
Respiratory syncytial virus is the leading cause of hospitalization in American infants.
Source: cbsnews.com
Page 40 - John Farley News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Farley Today - Breaking & Trending Today
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season – Metro US
WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year. RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly. […]
Source: metro.us
RSV antibody shot nirsevimab gets FDA approval to protect infants from virus
Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.
Source: abc11.com
FDA approves new drug Beyfortus to protect babies, toddlers from RSV
The FDA has approved usage of Beyfortus in babies and toddlers to protect them against the effects of the RSV lower respiratory tract disease.
Source: foxnews.com
FDA approves preventive RSV treatment for infants and toddlers
The Food and Drug Administration (FDA) has approved a treatment for the prevention of RSV among infants and toddlers, making it the first preventive drug for the common virus that surged last winter among small children. The FDA approved nirsevimab-alip, or Beyfortus, for the prevention of respiratory syncytial virus (RSV) among newborns and infants born…
Source: yahoo.com